Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis | April 6, 2021 |

Buzz on the Bullboards: T’is the Season for hot returns, or a lump of coal?

Once the U.S. Thanksgiving is in the rear-view, the mood among North American markets dramatically shifts. Traders must now juggle holidays, gifts, and vacations on one hand, and the end of their...
Jonathon Brown | December 1, 2022 |

Buzz on the Bullboards: Top stories drawing a curtain on the final week of 2022

The market mood is still cautious amid thin holiday trading. US stocks fell for a second day, and Treasury yields rose slightly.
Shoran Devi | December 29, 2022 |

New Rugged Handset Could Be A Game Changer For Siyata Mobile

First responders deserve better. Their traditional land mobile radio (LMR) setups are clunky, offer only low data speeds, and have limited coverage with dead zones that often slow down response times. Siyata Mobile Inc. ( NASDAQ: SYTA , Forum ) , with its push-to-talk ov...
Featured Submission | August 11, 2021 |

Aurora Cannabis, Canopy Growth, EXMceuticals - who will be the best turnaround story?

Cannabis shares are not in demand at the moment. About a year ago the growth potential and possibilities of the rediscovered historical medicinal plant seemed to be endless. Today it is different, there is a hangover mood. The hype back then led to a buyer's market. Investors ...
Mario Hose | February 25, 2020 |

Bayer, Siltronic, XPhyto - is it worthwhile to invest now?

Tuesday began with green lights for most listed companies in Germany. The opinions of analysts and company announcements make the stock prices - or they are driven by the mood of economic data. The Ifo Business Climate Index, for example, rose by 2.2 points to 92.6 points in...
Mario Hose | August 25, 2020 |

Siyata Mobile Accelerating Growth on Multiple Fronts

Expands its Global Footprint with Multiple New Contracts and a Key E-Commerce Distribution Agreement and Launches Innovative New Product Focusing on one specific niche market has long been a proven path to success. It’s also a potential road to failure if y...
Featured Submission | September 29, 2021 |

Siyata Mobile Still Bullish After Q2 Earnings Call

Earnings reports are useful for measuring financial milestones, but they don’t tell the whole story. Siyata Mobile (NASDAQ: SYTA, SYTAW) released their Q2 earnings on an October 15th call that included CEO Marc Seelenfreund, VP of Corporate Development Daniel...
Featured Submission | October 27, 2021 |

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports | September 25, 2019 |

Delivering innovative remote patient monitoring

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Cloud DX is emerging as the partner of choice among the largest global medical technology companies to provide innovative, best-in-class remote patient monitoring (RPM) solu...
Brieanna McCutcheon | September 22, 2022 |
1 2 3 4 5 6